Median Technologies SA (ALMDT.PA)

8.38 €

-0.04 (-0.48%)
Rating:
Recommendation:
-
Symbol ALMDT.PA
Price 8.38 €
Beta 2.214
Volume Avg. 0.02M
Market Cap 129.719M
Shares () -
52 Week Range 6.54-16.66
1y Target Est -
DCF Unlevered ALMDT.PA DCF ->
DCF Levered ALMDT.PA LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity 9193.22% Strong Buy
P/E -6.71 Strong Sell
P/B 274.31 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Fredrik Brag
Healthcare
Medical Devices
Paris

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.